2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1033376983 D.O.
Verify on CMS →

JASON BELL, D.O.

Endocrinology, Diabetes & Metabolism Physician in ABILENE, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 552 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
39%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.0687/100
▼ 7 pts below national avg 83.1 · [object Object]
Industry payments
$1.9K
29 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JASON BELL, D.O. reported a CMS MIPS final score of 76.0687/100 — below the 83.1 national average — and filed 5,206 Medicare Part D claims in 2023.

76.0687/100
MIPS score · -7 vs avg
5K
Part D claims, 2023
39%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JASON BELL, D.O.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

76 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JASON BELL, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JASON BELL, D.O.?

Below national average

NPI registry status

Active

Issued 05/19/2008

NPI 1033376983

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

5,206 97% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

76.0687/100 7.0312999999999874% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers

Texas providers

Endocrinology, Diabetes & Metabolism Physician share within Texas

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Texas

Medicare quality performance — MIPS

JASON BELL, D.O.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
76.0687/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 76.0687/100 vs national avg 83.1

0%100%National avg83%76.1%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 76.0687/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JASON BELL, D.O. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding D.O. credentials at 1904 PINE ST STE 200, ABILENE, TX, 79601, with a listed phone of (325) 670-5570. NPI 1033376983 was issued on 05/19/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BELL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,206 prescription claims written by this provider, covering 552 Medicare beneficiaries and totaling roughly $4.0 million in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.0687/100 for the 2023 performance year (Quality 83.923, Cost 25.0205), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1904 PINE ST STE 200
ABILENE, TX 79601

Provider Details

NPI 1033376983
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials D.O.
Gender Male
NPI Issued 05/19/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.0687
Final Score
Avg: 83.1
83.923
Quality
25.0205
Cost
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where JASON BELL, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HENDRICK PROVIDER NETWORK
ABILENE, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JASON BELL, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$1.9K

Largest payer

Tandem Diabetes Care, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JASON BELL, D.O.. To verify JASON BELL, D.O.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JASON BELL, D.O. — brand share 61.0%
Specialty average (est.)

61% brand-name claims vs 39% generic, on 5,206 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,206
Total Claims
$4.0M
Total Drug Cost
552
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
11,623
Total Day Supply
344,687
Brand vs Generic
61% brand / 39% generic
Brand Drug Cost
$3.8M
Generic Drug Cost
$40K

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
1.86
Gender Split
59% female / 41% male
Age Distribution
<65: 106, 65-74: 280, 75-84: 148, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JASON BELL, D.O. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
550
Ozempic
Semaglutide
516
Metformin Hcl Er
Metformin Hcl
414
Trulicity
Dulaglutide
353
Tresiba Flextouch U-200
Insulin Degludec
240
Synjardy Xr
Empagliflozin/Metformin Hcl
172
Novolog Flexpen
Insulin Aspart
162
Rosuvastatin Calcium
116
Jardiance
Empagliflozin
114
Tresiba Flextouch U-100
Insulin Degludec
114

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How JASON BELL, D.O. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

JASON BELL, D.O.'s 5,206 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BELL.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JASON BELL, D.O.'s specialty?
JASON BELL, D.O. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in ABILENE, Texas. Credentials: D.O..
How much does JASON BELL, D.O. prescribe under Medicare Part D?
In 2023, JASON BELL, D.O. wrote 5,206 Medicare Part D claims totaling $4.0M in drug costs for 552 beneficiaries.
What is JASON BELL, D.O.'s Medicare quality score?
JASON BELL, D.O. has a CMS MIPS Final Score of 76.0687/100 (Quality: 83.923, Cost: 25.0205). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JASON BELL, D.O. located?
JASON BELL, D.O. is located at 1904 PINE ST STE 200, ABILENE, TX, 79601. Phone: (325) 670-5570.
What is JASON BELL, D.O.'s NPI number?
JASON BELL, D.O.'s National Provider Identifier (NPI) is 1033376983, issued on 05/19/2008.
Does JASON BELL, D.O. prescribe more brand-name or generic drugs?
JASON BELL, D.O.'s prescribing is 61% brand-name and 39% generic drugs by claim count, with $3.8M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does JASON BELL, D.O. prescribe most often?
Based on 2023 Medicare Part D data, JASON BELL, D.O.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JASON BELL, D.O. accept Medicare?
JASON BELL, D.O. appears in CMS Medicare data with 5,206 Part D claims and 552 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JASON BELL, D.O.'s credentials?
JASON BELL, D.O.'s NPI is 1033376983 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology